← Back
$HALO All transactions

HALOZYME THERAPEUTICS, INC.

▼ SELL 10b5-1 Plan

$ Value

$259K

Shares

4,297

Price

$60

Filed

Apr 28

Insider

Name

Henderson Jeffrey William

Title

CIK

0001324015

Roles

Director

Transaction Details

Transaction Date

2025-04-28

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

28,811

Footnotes

The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 17, 2024 in accordance with Rule 10b5-1. | Represents a weighted average sales price per share. The shares were sold at prices ranging from $59.93 to $60.69. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Represents a weighted average sales price per share. The shares were sold at prices ranging from $60.97 to $61.02. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Filing Info

Accession No.

0001415889-25-011432

Form Type

4

Issuer CIK

0001159036

Henderson Jeffrey William's History

Date Ticker Type Value
2025-05-01 HALO A $0
2025-05-01 HALO A $0
2025-04-28 HALO $259K
2025-04-28 HALO $12K

Other Insiders at HALO (90d)

Insider Bought Sold Last
RAMSAY DAVID A
Interim CFO
2026-04-01
Torley Helen
PRESIDENT AND CEO
$3.2M 2026-04-06